Cytostatic conditioning in experimental allogeneic bone marrow transplantation: Busulfan causes less early gastrointestinal toxicity but Treosulfan results in improved immune reconstitution. (April 2014)
- Record Type:
- Journal Article
- Title:
- Cytostatic conditioning in experimental allogeneic bone marrow transplantation: Busulfan causes less early gastrointestinal toxicity but Treosulfan results in improved immune reconstitution. (April 2014)
- Main Title:
- Cytostatic conditioning in experimental allogeneic bone marrow transplantation: Busulfan causes less early gastrointestinal toxicity but Treosulfan results in improved immune reconstitution
- Authors:
- Bouazzaoui, Abdellatif
Dickhöfer, Sabine
Kreuz, Marina
Huber, Elisabeth
Holler, Ernst
Wolff, Daniel - Abstract:
- <abstract> <title>Abstract</title> <p> <italic>Background</italic>: Acute graft versus host disease (aGVHD) after allogeneic bone marrow transplantation (allo-BMT) is associated with significant morbidity and mortality. We evaluated the impact of the conditioning regimen on aGVHD comparing Treosulfan (Treo) and Busulfan (Bu) with total body irradiation (TBI).</p> <p> <italic>Methods</italic>: Using a haploidentical murine model, B6D2F1 mice conditioned with Bu (100 mg/kg)/Fludarabine (Flu, 500 mg/kg) or Treo (6000 mg/kg)/Flu (500 mg/kg) or TBI with 14 Gy received bone marrow cells and splenocytes (20 × 10<sup>6</sup>) from either syngeneic (B6D2F1) or allogeneic (C57BL/6N) donors in order to analyze aGVHD outcome.</p> <p> <italic>Results</italic>: Conditioning with Bu/Flu or Treo/Flu resulted in significantly reduced aGVHD severity and improved survival (<italic>p</italic> &lt; 0.05) after allo-BMT compared to TBI. On day 5 after allo-BMT, the organ damages of Bu/Flu conditioned animals were significantly reduced in association with diminished expression of tumor necrosis factor in serum compared to Treo/Flu. Interestingly, the early toxicity of Treo/Flu did not result in significantly higher aGVHD severity; furthermore, a significantly improved immune reconstitution of B220-positive B cells was observed at day 42 after Treo/Flu conditioning compared to Bu/Flu.</p> <p> <italic>Conclusion</italic>: Conditioning with Treo/Flu or Bu/Flu results in decreased aGVHD severity<abstract> <title>Abstract</title> <p> <italic>Background</italic>: Acute graft versus host disease (aGVHD) after allogeneic bone marrow transplantation (allo-BMT) is associated with significant morbidity and mortality. We evaluated the impact of the conditioning regimen on aGVHD comparing Treosulfan (Treo) and Busulfan (Bu) with total body irradiation (TBI).</p> <p> <italic>Methods</italic>: Using a haploidentical murine model, B6D2F1 mice conditioned with Bu (100 mg/kg)/Fludarabine (Flu, 500 mg/kg) or Treo (6000 mg/kg)/Flu (500 mg/kg) or TBI with 14 Gy received bone marrow cells and splenocytes (20 × 10<sup>6</sup>) from either syngeneic (B6D2F1) or allogeneic (C57BL/6N) donors in order to analyze aGVHD outcome.</p> <p> <italic>Results</italic>: Conditioning with Bu/Flu or Treo/Flu resulted in significantly reduced aGVHD severity and improved survival (<italic>p</italic> &lt; 0.05) after allo-BMT compared to TBI. On day 5 after allo-BMT, the organ damages of Bu/Flu conditioned animals were significantly reduced in association with diminished expression of tumor necrosis factor in serum compared to Treo/Flu. Interestingly, the early toxicity of Treo/Flu did not result in significantly higher aGVHD severity; furthermore, a significantly improved immune reconstitution of B220-positive B cells was observed at day 42 after Treo/Flu conditioning compared to Bu/Flu.</p> <p> <italic>Conclusion</italic>: Conditioning with Treo/Flu or Bu/Flu results in decreased aGVHD severity compared to TBI. Moreover, Treo/Flu was associated with improved immune reconstitution despite the early toxicity.</p> </abstract> … (more)
- Is Part Of:
- Immunopharmacology and immunotoxicology. Volume 36:Number 2(2014:Apr.)
- Journal:
- Immunopharmacology and immunotoxicology
- Issue:
- Volume 36:Number 2(2014:Apr.)
- Issue Display:
- Volume 36, Issue 2 (2014)
- Year:
- 2014
- Volume:
- 36
- Issue:
- 2
- Issue Sort Value:
- 2014-0036-0002-0000
- Page Start:
- 158
- Page End:
- 164
- Publication Date:
- 2014-04
- Subjects:
- Immunopharmacology -- Periodicals
Immunotoxicology -- Periodicals
Antibody-toxin conjugates -- Periodicals
Immunology -- Periodicals
615.37 - Journal URLs:
- http://informahealthcare.com/journal/ipi ↗
http://informahealthcare.com ↗ - DOI:
- 10.3109/08923973.2014.895743 ↗
- Languages:
- English
- ISSNs:
- 0892-3973
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4369.760200
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3809.xml